These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3568194)

  • 1. Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.
    Eastman A
    Chem Biol Interact; 1987 Mar; 61(3):241-8. PubMed ID: 3568194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY; Wilson JJ; Song Y; Lippard SJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
    Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
    J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D; Gaucheron F; Sip M; Leng M
    Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ; Barnard CF; Murrer BA; Kelland LR
    Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence specificity and reactivity of the binding of phenazine-tethered platinum complexes to DNA.
    Perrin LC; Cullinane C; McFadyen WD; Phillips DR
    Anticancer Drug Des; 1999 Jun; 14(3):243-52. PubMed ID: 10500499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).
    Pendyala L; Arakali AV; Sansone P; Cowens JW; Creaven PJ
    Cancer Chemother Pharmacol; 1990; 27(3):248-50. PubMed ID: 2265462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)].
    Mellish KJ; Barnard CF; Kelland LR; Harrap KR
    Int J Cancer; 1994 Oct; 59(1):65-70. PubMed ID: 7927906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Structural Distortions Induced by a Monofunctional Trinuclear Platinum Complex with Various Cross-Links Using Molecular Dynamics Simulation.
    Li C; Zhao X; Liu W; Yin F; Hu J; Zhang G; Chen G
    J Chem Inf Model; 2020 Mar; 60(3):1700-1708. PubMed ID: 32096984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity.
    Fan D; Yang X; Wang X; Zhang S; Mao J; Ding J; Lin L; Guo Z
    J Biol Inorg Chem; 2007 Jun; 12(5):655-65. PubMed ID: 17334797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
    Qu Y; Scarsdale NJ; Tran MC; Farrell NP
    J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical studies of the modification of DNA by antitumour platinum coordination complexes.
    Brabec V; Kleinwächter V; Butour JL; Johnson NP
    Biophys Chem; 1990 Apr; 35(2-3):129-41. PubMed ID: 2204440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
    Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
    Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum (II).
    Eastman A
    Anal Biochem; 1991 Sep; 197(2):311-5. PubMed ID: 1785684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.
    Kido Y; Khokhar AR; Siddik ZH
    Biochem Pharmacol; 1994 Apr; 47(9):1635-42. PubMed ID: 8185678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-mediated activation of anticancer platinum(IV) complexes.
    Eastman A
    Biochem Pharmacol; 1987 Dec; 36(23):4177-8. PubMed ID: 3689445
    [No Abstract]   [Full Text] [Related]  

  • 20. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.